GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Hims & Hers Health Inc (NYSE:HIMS) » Definitions » EPS (Diluted)

Hims & Hers Health (Hims & Hers Health) EPS (Diluted) : $-0.01 (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hims & Hers Health EPS (Diluted)?

Hims & Hers Health's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was $0.05. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.01.

Hims & Hers Health's EPS (Basic) for the three months ended in Mar. 2024 was $0.05. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.01.

Hims & Hers Health's EPS without NRI for the three months ended in Mar. 2024 was $0.05. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.01.

During the past 3 years, the average EPS without NRIGrowth Rate was 37.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Hims & Hers Health's highest 3-Year average EPS without NRI Growth Rate was 46.50% per year. The lowest was 37.30% per year. And the median was 41.90% per year.


Hims & Hers Health EPS (Diluted) Historical Data

The historical data trend for Hims & Hers Health's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hims & Hers Health EPS (Diluted) Chart

Hims & Hers Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
-2.07 -0.51 -0.58 -0.32 -0.11

Hims & Hers Health Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.03 -0.04 0.01 0.05

Competitive Comparison of Hims & Hers Health's EPS (Diluted)

For the Household & Personal Products subindustry, Hims & Hers Health's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hims & Hers Health's PE Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Hims & Hers Health's PE Ratio distribution charts can be found below:

* The bar in red indicates where Hims & Hers Health's PE Ratio falls into.



Hims & Hers Health EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Hims & Hers Health's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-23.546-0)/209.345
=-0.11

Hims & Hers Health's Diluted EPS for the quarter that ended in Mar. 2024 is calculated as

Diluted EPS (Q: Mar. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(11.128-0)/229.365
=0.05

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hims & Hers Health  (NYSE:HIMS) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Hims & Hers Health EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Hims & Hers Health's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Hims & Hers Health (Hims & Hers Health) Business Description

Traded in Other Exchanges
Address
2269 Chestnut Street, Suite 523, San Francisco, CA, USA, 94123
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
Executives
Andrew Dudum director, 10 percent owner, officer: Chief Executive Officer 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Oluyemi Okupe officer: Chief Financial Officer 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Soleil Boughton officer: See Remarks 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Lynne Chou O'keefe director 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Irene Becklund officer: Interim PFO/PAO 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Melissa Baird officer: Chief Operating Officer 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
David B Wells director C/O NETFLIX, INC., 100 WINCHESTER CIRCLE, LOS GATOS CA 95130
Alex Bard director 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Ivp Executive Fund Xvi, Llc 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 2, MENLO PARK CA 94025
Jules A. Maltz director 3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025
Christiane Pendarvis director 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Michael Chi officer: Chief Marketing Officer 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Somesh Dash 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025
Jack Abraham 10 percent owner 1 LETTERMAN DRIVE, SUITE C3500, SAN FRANCISCO CA 94129
Patrick Harrison Carroll officer: Chief Medicall Officer 2269 CHESTNUT STREET, # 523, SAN FRANCISCO CA 94123